|
(MoneyNewsWire.Net, January 30, 2018 ) The Global Companion Diagnostics Market reached nearly $3.2 billion in 2015. This market is expected to increase from $4.3 billion in 2016 to nearly $17.6 billion in 2021 at a compound annual growth rate (CAGR) of 32.3% for 2016-2021.
Browse details of 352 pages research report on Global Companion Diagnostics Market @ https://www.researchcosmos.com/reports/global-companion-diagnostics-market-analysis-with-forecasts-to-2022-growth-opportunities/143605992
Key to making personalized medicine a reality, companion diagnostics are playing a critical role in the accurate diagnosis of disease and enabling the efficient use of targeted therapies. This highly-complex sector continues to innovate, as exemplified by the development of liquid biopsy technology which introduces a new, non-invasive and cost-effective way for clinicians to make treatment adjustments.
As genomic research identifies new disease states and patient sub populations, the pharma industry and clinicians must be able to respond with specific targeted medicines. Companion diagnostics are changing the way powerful new targeted medicines are utilized to the benefit of patients, physicians and health payers.
Report Scope:
The scope of the report encompasses the major types of diagnostics technologies that have been used, the various industry structures such as the lab developed tests (LDTs) sector, and the major applications being commercialized and developed by a wide range of company types. It analyzes current market status, examines future market drivers and presents forecasts of growth over the next five years. Technology developments, including the latest trends, are discussed.
Avail Sample Market Brochure of the report for more information to evaluate report usefulness, Get a Copy @ https://www.researchcosmos.com/request/143605992
Report Includes:
- An overview of the market for companion diagnostics, including existing products on the market and detailed analysis of the competitive environments.
- Analyses of market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Examination of the current state of the industry, new technologies in assay development, and potential novel commercial venues in this area of the healthcare industry.
- Identification of major commercial sectors in companion diagnostics: oncology related products vs. cardiovascular diseases and other segments.
- Profiles of major players as well as a list of current companies that have new companion diagnostics products in development.
Inquire before buying @ https://www.researchcosmos.com/inquire/143605992
About Research Cosmos:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Contact Us:
Dani Rodriguez
Sales Manager
Research Cosmos
www.researchcosmos.com
dani@researchcosmos.com
# +1 888 709 8757
Research Cosmos
Dani
+1 888 709 8757
dani@researchcosmos.com
Source: EmailWire.Com 
|
